MUC20 mRNA levels were reduced in PI-resistant MM cell lines (PR) treated with CFZ or BTZ compared to those in PI-sensitive MM cell lines (PS) (Fig. 1A). The gene discussed is MUC20; the disease is Miyoshi myopathy.